Pyxis Oncology Newsroom

A Quick Look at Today's Ratings for Pyxis Oncology(PYXS.US), With a Forecast Between $7 to $10

Futu NewsNov 22 21:02

Pyxis Oncology Is Maintained at Outperform by RBC Capital

Dow JonesNov 21 23:09

H.C. Wainwright Maintains Pyxis Oncology(PYXS.US) With Buy Rating, Maintains Target Price $7

Futu NewsNov 21 20:32

RBC Capital Maintains Pyxis Oncology(PYXS.US) With Buy Rating, Raises Target Price to $10

Futu NewsNov 21 20:32

Pyxis Oncology Price Target Maintained With a $7.00/Share by HC Wainwright & Co.

Dow JonesNov 21 19:54

Pyxis Oncology Analyst Ratings

BenzingaNov 21 19:44

William Blair Initiates Pyxis Oncology(PYXS.US) With Hold Rating

Futu NewsNov 21 18:34

Stifel Maintains Pyxis Oncology(PYXS.US) With Buy Rating, Maintains Target Price $10

Futu NewsNov 13 21:36

RBC Capital Maintains Pyxis Oncology(PYXS.US) With Buy Rating, Maintains Target Price $7

Futu NewsNov 13 20:31

H.C. Wainwright Maintains Pyxis Oncology(PYXS.US) With Buy Rating, Maintains Target Price $7

Futu NewsNov 13 19:36

LifeSci Capital Maintains Pyxis Oncology(PYXS.US) With Buy Rating

Futu NewsNov 13 00:32

Pyxis Oncology Initiated at Overweight by Stephens & Co.

Dow JonesNov 8 20:14

Stephens Initiates Pyxis Oncology(PYXS.US) With Buy Rating, Announces Target Price $13

Futu NewsNov 8 05:31

LifeSci Capital Maintains Pyxis Oncology(PYXS.US) With Buy Rating

Futu NewsNov 4 21:36

Leerink Partners Maintains Pyxis Oncology(PYXS.US) With Buy Rating, Announces Target Price $12

Futu NewsOct 16 20:31

Leerink Partners维持Pyxis Oncology(PYXS.US)买入评级

Futu NewsSep 25 17:33

RBC Capital Maintains Pyxis Oncology(PYXS.US) With Buy Rating, Maintains Target Price $7

Futu NewsSep 19 19:33

Analysts Offer Insights on Healthcare Companies: Pyxis Oncology (PYXS), Spruce Biosciences (SPRB) and Envista Holdings (NVST)

TipRanksAug 20 15:05

HC Wainwright & Co. Reiterates Buy on Pyxis Oncology, Maintains $7 Price Target

BenzingaAug 16 19:22

Pyxis Oncology Analyst Ratings

BenzingaAug 16 19:22